Oncopeptides AB (publ) (STO:ONCO)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.780
-0.109 (-5.77%)
Sep 4, 2026, 5:29 PM CET

Oncopeptides AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
157.6182.26178.54173.41344.52362.19
Short-Term Investments
---0.030.352.11
Cash & Short-Term Investments
157.6182.26178.54173.44344.86364.3
Cash Growth
124.69%-53.93%2.94%-49.71%-5.33%-57.27%
Accounts Receivable
39.257.777.292.190.6711.87
Other Receivables
-8.676.2415.6816.2524.01
Receivables
39.2516.4313.5317.8716.9235.89
Inventory
11.798.244.372.43--
Prepaid Expenses
-5.346.195.431.717.42
Other Current Assets
-05.279.963.730.544.76
Total Current Assets
208.65117.72217.08202.9364.03412.37
Property, Plant & Equipment
13.3617.6827.1134.6320.4424.74
Other Intangible Assets
-----1.41
Other Long-Term Assets
---00.850.850.85
Total Assets
222.01135.4244.19238.38385.32439.38

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
16.780.718.1715.0328.2235.7
Accrued Expenses
-28.3215.1220.3817.2436.61
Current Portion of Leases
-7.727.275.13610.99
Current Income Taxes Payable
-1.151.730.580.30.05
Current Unearned Revenue
-0.230.070.5--
Other Current Liabilities
38.436.934.663.3233.91141.94
Total Current Liabilities
55.2145.0651.3644.9385.67225.29
Long-Term Debt
135.17126.68121.89106.49--
Long-Term Leases
-4.9812.5519.67-3.21
Other Long-Term Liabilities
6.717.564.1110.515.360.01
Total Liabilities
197.09194.29189.91181.691.03228.51

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
43.9230.323.9110.5110.488.37
Additional Paid-In Capital
-5,8145,6845,4145,4034,982
Retained Earnings
--5,900-5,651-5,366-5,116-4,778
Comprehensive Income & Other
-18.99-3.21-2.84-2.2-2.3-0.92
Shareholders' Equity
24.93-58.8954.2956.78294.29210.87
Total Liabilities & Equity
222.01135.4244.19238.38385.32439.38

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
135.17139.39141.72131.29614.19
Net Cash (Debt)
22.44-57.1336.8242.15338.86350.11
Net Cash Growth
---12.65%-87.56%-3.21%-57.98%
Net Cash Per Share
0.08-0.250.220.474.124.65
Filing Date Shares Outstanding
395.29272.71215.1994.694.3175.29
Total Common Shares Outstanding
395.29272.71215.1994.694.3175.29
Working Capital
153.4472.66165.73157.97278.36187.08
Book Value Per Share
0.06-0.220.250.603.122.80
Tangible Book Value
24.93-58.8954.2956.78294.29209.46
Tangible Book Value Per Share
0.06-0.220.250.603.122.78
Machinery
-16.4616.4616.115.9914.42